Clozapine and haloperidol modulate N-methyl-D-aspartate- and non-N- methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons In Vitro

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 1, 1997, Pages 226-234

  Arvanov, V L ^a   Liang, X ^a   Schwartz, J ^a   Grossman, S ^a   Wang, R Y ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; FLUOXETINE; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RACLOPRIDE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; IN VITRO STUDY; MALE; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; VOLTAGE CLAMP;

ACTION POTENTIALS; ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; ELECTRIC STIMULATION; HALOPERIDOL; MALE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION;

EID: 0030881619     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. AKBARIAN, S., SUCHER, N. J., BRADLEY, D., TAFAZZOLI, A., TRINH, D., HETRICK, W. P., POTKIN, S. G., SANDMAN, C. A., BUNNEY, W. E., JR. AND JONES, E. G.: Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J. Neurosci. 16: 19-30, 1996.
2. ARVANOV, V., MAGRO, P. AND WANG, R.: Pre- and postsynaptic actions of hallucinogens on NMDA-neurotransmission in the rat medial prefrontal cortical (mPFC) slices. Neurosci. Abstr. 22: 65, 1996.
3. ARVANOV, V., STEPANIAN, A. AND AYRAPETIAN, S.: Effect of cAMP, Ca, and phorbol esters on ouabain-induced depression of acetylcholine responses in Helix neurons. Cell. Mol. Neurobiol. 12: 153-161, 1992.
4. ARVANOV, V. AND WANG, R.: NMDA-evoked response in pyramidal neurons of the rat medial prefrontal cortex slices consists of NMDA- and non-NMDA components. Brain Res., in press, 1997.
5. ARVANOV, V. L. AND USHERWOOD, P. N. R.: Concentration jump studies of intracellularly dialyzed Xenopus oocytes show desensitization of kainate receptors. Neurosci Lett. 129: 201-204, 1991.
6. ASHBY, C. R., JR. AND WANG, R. Y.: Pharmacological actions of the atypical antipsychotic drug clozapine: A review. Synapse 24: 349-394, 1996.
7. BALDESSARINI, R. J., COHEN, B. M. AND TEICHER, M. H.: Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Arch. Gen. Psychiat. 45: 79-91, 1988.
8. BANERJEE, S. P., ZUCK, L. G., YABLONSKY-ALTER, E. AND LIDSKY, T. I.: Glutamate agonist activity: Implications for antipsychotic drug action and schizophrenia. Neuroreport 6: 2500-2504, 1995.
9. BERMAN, K. F. AND WEINBERGER, D. R.: The prefrontal cortex in schizophrenia and other neuropsychiatriC diseases: In vivo physiological correlates of cognitive deficits. Prog. Brain Res. 85: 521-537, 1990.
10. B receptor antagonists: From synthesis to therapeutic applications. Trends Pharmacol. Sci. 14: 391-394, 1993.
11. BURGARD, E. C. AND HABLITZ, J. J.: Developmental changes in NMDA and non-NMDA receptor-mediated synaptic potentials in rat neocortex. J. Neurophysiol. 69: 230-240, 1993.
12. CARLSSON, M. AND CARLSSON, A.: Interactions between glutamatergic and monoaminergic systems within the basal ganglia: Implications for schizophrenia and Parkinson's disease. Trends Pharmacol. Sci. 13: 272-276, 1990.
13. CAULI, B., AUDINAT, E., LAMBOLEZ, B., ANGULO, M. C., ROPERT, N., TSUZUKI, K., HESTRIN, S. AND ROSSIER, J.: Molecular and physiological diversity of cortical nonpyramidal cells. J. Neurosci. 17: 3894-3906, 1997.
14. CONNORS, B. W. AND GUTNICK, M. J.: Intrinsic firing patterns of diverse neocortical neurons. Trends Pharmacol. Sci. 13: 99-104, 1990.
15. CORBETT, R., CAMACHO, F., WOODS, A. T., KERMAN, L. L., FISHKIN, R. J., BROOKS, K. AND DUNN, R. W.: Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology 120: 67-74, 1995.
16. DALY, D. A. AND MOGHADDAM, B.: Actions of haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats. Neurosci. Lett. 152: 61-64, 1993.
17. DEAKIN, J. F. W., SLATER, P., SIMPSON, M. D. C., GILCHRIST, A. C., SKAN, W. J., ROYSTON, M. C., REYNOLDS, G. P. AND CROSS, A. J.: Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J. Neurochem. 52: 1781-1786, 1989.
18. DEUTSCH, S. I., MASTRPAOLO, J., SCHWARTZ, B. L., ROSSE, R. B. AND MORIHISA, J. M.: A 'glutamatergic hypothesis' of schizophrenia: Rationale for pharmacology with glycine. Clin. Neuropharmacol. 12: 1-13, 1989.
19. FARBER, N., FOSTER, J., DUHAN, N. L. AND OLNEY, J. W.: Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity. Schizophr. Res. 21: 33-37, 1996.
20. 2 receptor binding in risperidone-treated schizophrenic patients. J. Clin. Psychopharmacol. 15: 19S-23S, 1995.
21. FINKEL, A. S. AND REDMAN, S. J.: Optimal voltage clamping with single microelectrodes. In Voltage and Patch Clamping with Microelectrodes, ed. by T. G. Smith, A. Lecar, S. J. Redman and P. W. Gage, pp. 95-120, Baltimore, Williams & Wilkins, 1985.
22. FITZGERALD, L. W., DEUTCH, A. Y., GASIC, G., HEINEMANN, S. F. AND NESTLER, E. J.: Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J. Neurosci. 15: 2453-2461, 1995.
23. GLEASON, S. D. AND SHANNON, H. E.: Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology 129: 79-84, 1997.
24. GROTTA, J.: Safety and tolerability of the glutamate antagonist CGS 19755 in acute stroke patients. Stroke 25: 255, 1994.
25. HALLER, E. AND BINDER, R. L.: Clozapine and seizures. Am. J. Psychiatry 147: 1069-1071, 1990.
26. HALLIWELL, J. V. AND ADAMS, P. R.: Voltage-clamp analysis of muscarinic excitation in hippocampal neurons. Brain Res. 250: 71-92, 1982.
27. HARRISON, P. J., MCLAUGHLIN, D. AND KERWIN, R. W.: Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet 337: 450-452, 1991.
28. HERRLING, P. L.: D-CPPene (SDZ EAA 494), a competitive NMDA antagonist: Results from animal models and first results in humans. Neuropsychopharmacology 10: 591S, 1994.
29. HOLMES, K., KEELE, B., ARVANOV, V. AND SHINNICK-GALLAGHER, P.: Metabotropic glutamate receptor agonist-induced hyperpolarization in rat basolateral amygdala neurons: Receptor characterization, second messengers and ion channels. J. Neurophysiol. 76: 3059-3069, 1996.
30. ISHIMARU, M., KURUMAJI, A. AND TORU, M.: Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: Evidence for glutamate hypothesis. Biol. Psychiat. 35: 84-95, 1994.
31. KALIVAS, P. W., CHURCHILL, L. AND KLITENICK, M. A.: The circuitry mediating the translation of motivational stimuli into adaptive motor responses. In Limbic Motor Circuits and Neuropsychiatry, ed. by P. W. Kalivas and C. D. Barnes, pp. 237-287, CRC Press, Boca Raton, FL, 1993.
32. KAWAGUCHI, Y.: Groupings of nonpyramidal and pyramidal cells with specific physiological and morphological characteristics in rat frontal cortex. J. Neurophysiol. 69: 416-431, 1993.
33. KAWAGUCHI, Y. AND KUBOTA, Y.: Physiological and morphological identification of somatostain- or vasoactive intestinal polypeptide-containing cells among GABAergic cell types in rat frontal cortex. J. Neurosci. 16: 2701-2715, 1996.
34. 2A antagonist with a favorable central nervous system safety profile. J. Pharmacol. Exp. Ther. 277: 968-981, 1996.
35. KERWIN, R., PATEL, S. AND MELDRUM, B.: Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem. Neuroscience 39: 25-32, 1990.
36. KIM, J. S., KORNHUBER, J., SCHMID-BURGK, W. AND HOLZMULLER. B.: Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci. Lett. 20: 379-382, 1980.
37. 3H]raclopride: A potent substituted benzamide drug with high affinitv for dopamine D2 receptors in the rat brain. Biochem. Pharmacol. 34: 2251-2255, 1985.
38. KORNHUBER, J. AND KORNHUBER, M. E.: Presynaptic dopaminergic modulation of cortical input to the striatum. Life Sci. 39: 669-674, 1986.
39. 3H-MK-801 binding studies in postmortem brain regions of schizophrenic patients. J. Neural Transm. 77: 231-236, 1989.
40. KRISTENSEN, J. D., SVENSSON, B. AND GORDH, T.: The NMDA receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain 51: 249-253, 1992.
41. KUBOTA, T., JIBIKI, I., KISHIZAWA, S. AND KUROKAWA, K.: Clozapine-induced potentiation of synaptic responses in the perforant path-dentate gyrus pathway in chronically prepared rabbits. Neurosci. Lett. 211: 21-24, 1996.
42. LAHTI, A. C., HOLCOMB, H. H., MEDOFF, D. R. AND TAMMINGA, C. A.: Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport 6: 869-72, 1995.
43. LANCASTER, B. AND NICOLL, R. A.: Properties of two calcium-activated hyperpolarizations in rat hippocampal neurons. J. Physiol. 389: 187-203, 1987.
44. LIDSKY, T. I., YABLONSKY-ALTER, E., ZUCK, L. AND BANERJEE, S. P.: Antiglutamatergic effects of clozapine. Neurosci. Lett. 163: 155-158, 1993.
45. LYNCH, D. R. AND GALLAGHER, M. J.: Inhibition of N-methyl-D-aspartate receptors by haloperidol: Developmental and pharmacological characterization in native and recombinant receptors. J. Pharmacol. Exp. Ther. 279: 154-161, 1996.
46. MADISON, D. V., LANCASTER, B. AND NICOLL, R. A.: Voltage clamp analysis of cholinergic action in the hippocampus. J. Neurosci. 7: 733-741, 1987.
47. MARTIN, D., BUSTOS, G., BOWE, M., BRAY, S. AND NADLER, V.: Autoreceptor regulation of glutamate and aspartate release from slices of the hippocampal CA1 aria. J. Neurochem. 56: 1647-1655, 1991.
48. MARTIN, D., THOMPSON, M. A. AND NADLER, J. V.: The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1. Eur. J. Pharmacol. 250: 473-447, 1993.
49. 2 dopamine receptors mediating inhibition of release. J. Pharmacol. Exp. Ther. 251: 1142-1146, 1989.
50. 2 dopamine receptors are located on striatal glutamatergic nerve terminals. J. Pharmacol. Exp. Ther. 247: 680-684, 1988a.
51. 2 receptors. Eur. J. Pharmacol. 145: 31-38, 1988b.
52. 2A receptors. Eur. J. Pharmacol. 280: R9-R11, 1995.
53. MCCORMICK, D. A., CONNORS, B. W., LIGHTHALL, J. W. AND PRINCE, D. A.: Comparative electrophysiology of pyramidal and sparsely spiny neurons of the neocortex, J. Neurophysiol. 54: 782-806, 1985.
54. MCDONALD, J., MODY, I. AND SALTER, M. W.: Regulation of N-methyl-D-aspartate receptors revealed by intracellular dialysis of murine neurons in culture. J Physiol. 414: 17-34, 1989.
55. MOGHADDAM, B.: Recent basic findings in support of excitatory amino acid hypotheses of schizophrenia. Prog. Neuro-Psychopharmacol Biol. Psychiatry. 18: 859-870, 1994.
56. 3H-kaimc acid binding in the prefrontal cortex in schizophrenia. Neurosci. Lett. 40: 245-250, 1983.
57. 2 receptor occupancy in relation to clozapine serum concentration: A PET study of schizophrenic patients. Am. J. Psychiatry 152: 1444-1449, 1995.
58. NOWAK, L., BREGESTOVSKI P., ARCHER P., HERBET A. AND PROCHIANTZ, A.: Magnesium gates glutamate-activated channels in a mouse central neurons. Nature 307: 462-465, 1984.
59. OLNEY, J. W. AND FARBER, N. B.: Glutamate receptor disfunction and schizophrenia. Arch. Gen. Psychiatry 52: 998-1007, 1995.
60. PENCEK, T. L., SCHAUF, C. L. AND DAVIS, F. A.: The effect of halopendol on the ionic currents in the voltage-clamped node of ranvier. J. Pharmacol. Exp. Ther. 204: 400-405, 1978.
61. 3H-D-aspartate release by D2 dopamine receptors in rat striatal slices. Synapse 2: 450-456, 1988.
62. SCHWEITZER, P., MADAMBA, S., CHAMPAGNAT, J. AND SIGGINS, G. R.: Somatostetin inhibition of hippocampal CA1 pyramidal neurons: Mediation by arachidonic acid and its metabolites. J. Neurosci. 13: 2033-2049, 1993.
63. SEEMAN, P.: Dopamine receptor sequences: Therapeutic levels of neuroleptice occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacolgy 7: 261-284, 1992.
64. SIMPSON, M. D., SLATER, P., ROYSTON, M. C. AND DEAKIN, J. F.: Alterations in phencyclidine and sigma binding sites in schizophrenic brains: Effects of disease process and neuroleptic medication. Schizophr. Res. 6: 41-48, 1991.
65. TANAKA, E. AND NORTH, A. R.: Action of 5-hydroxytryptamine on neurons of rat cingulate cortex. J. Neurophysiol. 89: 1749-1757, 1993.
66. TARAZI, F. I., FLORIJI, J. AND CREESE, I.: Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics. Psychopharmacology 128: 371-379, 1996.
67. ULAS, J. AND COTTMAN, C. W.: Excitatory amino acid receptors in schizophrenia. Schizophr. Bull. 19: 105-117, 1993.
68. ULAS, J., NGUYEN, L. AND COTTMAN, C. W,: Chronic halopendol treatment enhances binding to NMDA receptors in rat cortex. Neuroreport 4:1049-1051, 1993.
69. 4 receptor gene with high affinity for the antipsychotic clozapine. Nature 350: 614-619, 1991.
70. VERGHESK, C., KESSEL, J. B. AND SIMPSON, G. M.: Pharmacokinetics of neuroleptics. Psychopharmacol. Bull. 27: 551-563, 1991.
71. WACHTEL, H. AND TURSKI, L.: Glutamate: A new target in schizophrenia. Trends Pharmacol. Sci. 11: 219-220, 1990.
72. WANG, R. Y. AND ARVANOV, V. L.: The potentiation of NMDA-induced inward current by antipsychotics in cortical cells. Neuroscience Abstr. 22: 65, 1996.
73. 2A receptors to potentiate NMDA response in pyramidal cells of the medial prefrontal cortex. Schizophr. Res. 24: 83, 1997.
74. + channels in central and peripheral nerve membranes. Eur. J. Pharmacol. 224: 57-62, 1992.
75. WUARIN, J. P., PEACOCK, W. J. AND DUBEK, F. E.: Single-electrode voltage clamp analysis of the N-methyl-D-aspartate component of synaptic responses in neocortical slices from children with intractable epilepsy. J. Neurophysiol. 67: 84-93, 1992.
76. YAMAMOTO, B. K., PEHEK, E. A. AND MELTZER, H. Y.: Brain region effects of clozapine on amino acid and monoamine transmission. J. Clin. Psychiatry 55: suppl., 8-14, 1994.
77. YANG, C. R., SEAMANS, J. K. AND GORELOVA, N.: Electrophysiological and morphological properties of layers V-VI principal pyramidal cells in rat prefrontal cortex in vitro. J Neurosci. 16: 1904-1921, 1996.
78. ZAR, J. H.: Biostatistical Analysis. Prentice Hall, Upper Saddle River, NJ, 1996.
79. ZILLES. K.: The Cortex of the Rat. Springer-Verlag, Berlin/Heidelberg, 1985.